クオリプスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/01/10 | 4,850 | 4,855 | 4,770 | 4,780 | -125 | -2.5% | 81,600 |
| 2025/01/09 | 4,890 | 4,980 | 4,785 | 4,905 | +10 | +0.2% | 108,700 |
| 2025/01/08 | 4,950 | 5,070 | 4,840 | 4,895 | +25 | +0.5% | 173,600 |
| 2025/01/07 | 4,760 | 4,890 | 4,670 | 4,870 | +110 | +2.3% | 126,200 |
| 2025/01/06 | 4,720 | 4,880 | 4,620 | 4,760 | +150 | +3.3% | 158,400 |
| 2024/12/30 | 4,540 | 4,660 | 4,485 | 4,610 | +105 | +2.3% | 110,700 |
| 2024/12/27 | 4,390 | 4,635 | 4,390 | 4,505 | +185 | +4.3% | 251,600 |
| 2024/12/26 | 4,515 | 4,525 | 4,320 | 4,320 | -240 | -5.3% | 288,700 |
| 2024/12/25 | 4,705 | 4,725 | 4,520 | 4,560 | -155 | -3.3% | 178,700 |
| 2024/12/24 | 4,720 | 4,880 | 4,655 | 4,715 | -25 | -0.5% | 132,700 |
| 2024/12/23 | 4,650 | 4,800 | 4,600 | 4,740 | +20 | +0.4% | 121,200 |
| 2024/12/20 | 4,585 | 4,750 | 4,555 | 4,720 | +135 | +2.9% | 151,600 |
| 2024/12/19 | 4,680 | 4,820 | 4,550 | 4,585 | -200 | -4.2% | 185,700 |
| 2024/12/18 | 5,130 | 5,490 | 4,770 | 4,785 | -545 | -10.2% | 639,300 |
| 2024/12/17 | 4,590 | 5,330 | 4,455 | 5,330 | +705 | +15.2% | 152,100 |
| 2024/12/16 | 4,675 | 4,705 | 4,590 | 4,625 | -70 | -1.5% | 142,100 |
| 2024/12/13 | 4,790 | 4,790 | 4,620 | 4,695 | -50 | -1.1% | 120,500 |
| 2024/12/12 | 4,855 | 4,910 | 4,715 | 4,745 | -90 | -1.9% | 164,700 |
| 2024/12/11 | 4,805 | 4,925 | 4,780 | 4,835 | -15 | -0.3% | 108,800 |
| 2024/12/10 | 4,730 | 4,940 | 4,730 | 4,850 | +180 | +3.9% | 208,400 |
| 2024/12/09 | 4,905 | 4,910 | 4,635 | 4,670 | -230 | -4.7% | 246,100 |
| 2024/12/06 | 4,955 | 4,970 | 4,830 | 4,900 | -95 | -1.9% | 204,800 |
| 2024/12/05 | 5,030 | 5,190 | 4,960 | 4,995 | -105 | -2.1% | 221,000 |
| 2024/12/04 | 5,500 | 5,500 | 5,100 | 5,100 | -370 | -6.8% | 449,100 |
| 2024/12/03 | 5,170 | 5,490 | 5,020 | 5,470 | +300 | +5.8% | 529,400 |
| 2024/12/02 | 5,290 | 5,540 | 5,160 | 5,170 | +80 | +1.6% | 720,900 |
| 2024/11/29 | 4,830 | 5,160 | 4,740 | 5,090 | +240 | +4.9% | 478,200 |
| 2024/11/28 | 4,805 | 4,950 | 4,680 | 4,850 | +105 | +2.2% | 722,100 |
| 2024/11/27 | 4,600 | 4,770 | 4,450 | 4,745 | -55 | -1.1% | 655,300 |
| 2024/11/26 | 4,905 | 5,110 | 4,655 | 4,800 | -240 | -4.8% | 1,061,200 |
| 2024/11/25 | 5,250 | 5,500 | 5,020 | 5,040 | -140 | -2.7% | 529,600 |
| 2024/11/22 | 5,980 | 5,980 | 5,020 | 5,180 | -500 | -8.8% | 1,994,800 |
| 2024/11/21 | 5,680 | 5,680 | 5,680 | 5,680 | +705 | +14.2% | 18,800 |
| 2024/11/20 | 4,650 | 4,975 | 4,585 | 4,975 | +700 | +16.4% | 379,100 |
| 2024/11/19 | 4,960 | 4,975 | 4,145 | 4,275 | -785 | -15.5% | 1,445,900 |
| 2024/11/18 | 4,650 | 5,470 | 4,585 | 5,060 | -170 | -3.3% | 709,300 |
| 2024/11/15 | 5,930 | 6,060 | 5,050 | 5,230 | -820 | -13.6% | 573,500 |
| 2024/11/14 | 5,350 | 6,430 | 5,350 | 6,050 | -100 | -1.6% | 584,400 |
| 2024/11/13 | 6,370 | 6,550 | 6,140 | 6,150 | -220 | -3.5% | 194,100 |
| 2024/11/12 | 6,390 | 6,680 | 6,310 | 6,370 | -30 | -0.5% | 206,400 |
| 2024/11/11 | 6,550 | 6,660 | 6,330 | 6,400 | -250 | -3.8% | 237,900 |
| 2024/11/08 | 7,030 | 7,190 | 6,610 | 6,650 | -440 | -6.2% | 376,500 |
| 2024/11/07 | 7,250 | 7,380 | 7,050 | 7,090 | -210 | -2.9% | 152,600 |
| 2024/11/06 | 7,000 | 7,430 | 7,000 | 7,300 | +20 | +0.3% | 215,000 |
| 2024/11/05 | 7,740 | 7,840 | 7,200 | 7,280 | -600 | -7.6% | 188,100 |
| 2024/11/01 | 7,920 | 8,030 | 7,800 | 7,880 | -280 | -3.4% | 118,100 |
| 2024/10/31 | 8,170 | 8,250 | 8,050 | 8,160 | -120 | -1.4% | 101,800 |
| 2024/10/30 | 8,040 | 8,380 | 7,880 | 8,280 | +290 | +3.6% | 142,100 |
| 2024/10/29 | 7,780 | 7,990 | 7,720 | 7,990 | +180 | +2.3% | 94,700 |
| 2024/10/28 | 7,790 | 8,050 | 7,760 | 7,810 | -10 | -0.1% | 105,900 |
101～
150
件表示中 / 478件
類似銘柄と比較する
現在ご覧いただいている「クオリプス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| クオリプス | 607,000円 | +237.1% | - | 0.00% | - | 8.91倍 |
|
大阪大学発ベンチャー。ｉＰＳ細胞由来のシートによる世界初の重症心不全治療法開発に注力 |
| タウンズ | 58,700円 | +4.6% | +6.1% | 4.77% | 10.00倍 | 3.70倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
| ヘリオス | 48,400円 | +150.0% | - | 0.00% | - | 23.81倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| 生化学 | 63,800円 | -9.6% | -30.2% | 4.70% | 25.79倍 | 0.47倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。２種のヒアルロン酸製剤は科研と参天が販売 |
| 富士製薬 | 131,200円 | +15.7% | +5.3% | 3.47% | 9.48倍 | 0.70倍 |
|
女性医療、急性期医療の２領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
市場注目の銘柄
チャート関連のコラム
